And this year alone, since December 31st, AB1 has issued more capital, another 69m shares. Some will go to WAX (approx 3.5m I think) and I presume Talenthouse (12.7m) and to whatever the current trading halt deal is. There is a lot of dilution occurring which the market is acknowledging in the share price. Expecting this to bounce to 20c or whatever is not as realistic as it was several years ago because the number of shares on issue is four times what it was.
I'm not saying it wont or it cant, but with 750m shares on issue now 20c is a $150m company. In 2015 it would have meant a $25m company.
There have been lots of acquisitions and partnerships and no, they have not all translated in to sales. What revenue do we have from the Red Robot colloboration? The Tokyo Casino Project, Masterchef, Tribeflame, HTC?
I'm simply suggesting that these seeds take time to grow and they won't all be successful. I'm also suggesting that the market has already priced in a premium for growth of AB1. Capital has been issued and we are yet to see revenues, but thats simply the nature of investing. When we do see revenues there will already be some of that priced in so a share bounce won't be the same as if it hadn't.
Its great to be bullish and I am on AB1 (see my sentiment and position). Its often a mistake to value a company based on its past performance but you need to temper your expectations for future performance too. The best case scenarios don't always play out and when you are excited about a stock you forget to look for the pitfalls.
- Forums
- ASX - By Stock
- AB1
- Ann: Trading Halt
Ann: Trading Halt, page-43
Featured News
Add AB1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online